Apellis Pharmaceuticals
APLS
APLS
276 hedge funds and large institutions have $3.17B invested in Apellis Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 88 increasing their positions, 101 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 273 → 276 (+3)
13% less repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 101
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
276
Holding in Top 10
2
Calls
$106M
Puts
$28.3M
Top Buyers
| 1 | +$180M | |
| 2 | +$80.5M | |
| 3 | +$29.6M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$24.8M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$17.9M |
Top Sellers
| 1 | -$78M | |
| 2 | -$66.7M | |
| 3 | -$51.9M | |
| 4 |
Amundi
Paris,
France
|
-$34.3M |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
-$24.3M |
